Incorporation of Al2O3 and ZrO2 ceramics to AZ31 magnesium alloys composite coating using micro-arc oxidation method

In this research, a composite coating with Al₂O₃ and ZrO₂ particles have been applied on AZ31 magnesium alloy by micro-arc oxidation (MAO) technique. The alkaline electrolyte included a constant based composition and different composition of the Al₂O₃ and ZrO₂ additives. Microstructure observations reveal that the surface pores of composite coating reduced during addition of ZrO₂ and Al₂O₃ ceramic particles. The hardness of coating increased from about 380 for non-added to 620 MPa for Al₂O₃+ZrO₂ added coating and wear rate reduced about 8 times. Wettability of the coating increased by incorporation of Al₂O₃ and/or ZrO₂ particles while, Al₂O₃ is more effective than ZrO₂. Addition of the ceramic particles enhanced the hydrophilicity properties of surface in wettability test and a contact angle of 43° was obtained for coating including Al₂O₃+ZrO₂. The antibacterial properties of MAO coatings showed that S. aureus bacterium is more sensitive to the zirconia and alumina particle than S. typhimurium bacterium after 24 h of incubation.

Association of aplastic anaemia and Fanconi's disease with HLA-DRB1 alleles

One of the most fascinating areas of research within the field of histocompatibility at present time concerns an observation that a major human histocompatibility system, human leucocyte antigen (HLA), is deeply involved in the development of a great number of diseases. Major histocompatibility complex is the most polymorphic system in the genome of different species. Recognition of HLA alleles could be useful in transplantation and disease studies. Genetic construct of HLA DRB1 was studied in Iranian normal populations and patients with aplastic anaemia and Fanconi's disease. DNA was extracted from the whole blood of 466 normal, 35 aplastic anaemia and 10 Fanconi's individuals. Then DRB1 gene polymorphism was studied by polymerase chain reaction-sequence-specific primer method. The HLA DRB1 gene analysis showed increase of DRB1*07 in aplastic anaemia patients compared to normal population (P = 0.02). According to this study, the frequency of DRB1*07 in normal individuals was 8.3, and in aplastic anaemia patients, 15.7%. Additionally, the frequency of DRB1*04 in normal, aplastic anaemia and Fanconi's individuals was 10, 5.7 and 20%, respectively. Our results of investigation showed correlation between some HLA alleles with the studied diseases. We reported the frequency of various DR types in aplastic and Fanconi's patients. This study could imply the possible role of HLA-DRB1*07 in the incidence of aplastic anaemia. Moreover, the frequency of DRB1*04, DRB1*03 and DRB1*15 alleles showed intermediate correlation with Fanconi's anaemia.